A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis Tanjila KhanRicardo J. JoseMaria Mouyis Review Open access 27 August 2021 Pages: 1463 - 1475
Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria Mihail A. BoyanovAnna-Maria BorissovaReneta T. Petkova Review Open access 06 September 2021 Pages: 1477 - 1491
Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers William SaalfeldAmanda M. MixonEileen J. Lydon Review Open access 14 September 2021 Pages: 1493 - 1517
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis Alen ZabottiOrazio De LuciaRoberto Caporali Review Open access 01 October 2021 Pages: 1519 - 1534
Esophageal Dysfunction in Systemic Sclerosis: An Update Bo LiJunqing YanXuan Wang Review Open access 09 October 2021 Pages: 1535 - 1549
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study Jeffrey R. CurtisSoumya D. ChakravartySergio Schwartzman Original Research Open access 20 August 2021 Pages: 1551 - 1563
Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis Katja BlaschkeRebecca Fischer-BetzIngrid Schubert Original Research Open access 24 August 2021 Pages: 1565 - 1584
Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study Sei MuraokaZento Yamadathe ABT-ATS study group Original Research Open access 26 August 2021 Pages: 1585 - 1601
Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis Steven L. TruongJasmine ChinPhilip C. Robinson Original Research Open access 26 August 2021 Pages: 1603 - 1616
Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial Alberto MiglioreTomasz BlicharskiJean-Yves Reginster Original Research Open access 30 August 2021 Pages: 1617 - 1636
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis Elizabeth A. HoldsworthBethany DonaghyDaniel E. Furst Original Research Open access 02 September 2021 Pages: 1637 - 1649
Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy Suzanne AnjohrinAnna SheahanVictor S. Sloan Original Research Open access 07 September 2021 Pages: 1651 - 1659
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data Markus RehbergClemens Giegerichthe MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators Original Research Open access 14 September 2021 Pages: 1661 - 1675
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials Philip J. MeaseDafna D. GladmanIain B. McInnes Original Research Open access 18 September 2021 Pages: 1677 - 1691
The Risk Factors of Exacerbation in Interstitial Pneumonia With Autoimmune Features: A Single-Center Observational Cohort Study Okinori MurataKatsuya SuzukiMakoto Maemondo Original Research Open access 18 September 2021 Pages: 1693 - 1710
Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study Xianmin MengQianqian WangHongzhou Lu Original Research Open access 23 September 2021 Pages: 1711 - 1724
Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA Alexis OgdieWesley MatthiasChristopher D. Saffore Original Research Open access 25 September 2021 Pages: 1725 - 1739
Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey Laura C. CoatesValderilio F. AzevedoSamantha Howland Original Research Open access 27 September 2021 Pages: 1741 - 1758
Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis Thomas J. SchnitzerFrancis BerenbaumKenneth M. Verburg Original Research Open access 04 October 2021 Pages: 1759 - 1774
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis Irene van der Horst-BruinsmaCorinne Miceli-RichardEffie Pournara Original Research Open access 07 October 2021 Pages: 1775 - 1787
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1 Vibeke StrandPhilip J. MeaseDafna D. Gladman Original Research Open access 12 October 2021 Pages: 1789 - 1808
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study Nicolò GirolimettoPierluigi MacchioniFrancesco Caso Original Research Open access 15 October 2021 Pages: 1809 - 1826
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2 Vibeke StrandFilip Van den BoschPeter Nash Original Research Open access 18 October 2021 Pages: 1827 - 1844
Clinical Characteristics of Psoriatic Arthritis in Chinese Patients: A Cross-Sectional Study Zhibo SongXuerong DengZhuoli Zhang Original Research Open access 19 October 2021 Pages: 1845 - 1857
Significance of Macrophage Subtypes in the Peripheral Blood of Children with Systemic Juvenile Idiopathic Arthritis Dan FengWen-Yan HuangYu-Jie Hu Original Research Open access 25 October 2021 Pages: 1859 - 1870
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus Anca D. AskanaseDale WrightRichard A. Furie Brief Report Open access 03 September 2021 Pages: 1871 - 1886
Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study Debellemanière GuillaumeBouvet MagalieGatinel Damien Brief Report Open access 16 September 2021 Pages: 1887 - 1895
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients Fabio Massimo PerrottaSilvia ScriffignanoEnnio Lubrano Brief Report Open access 20 September 2021 Pages: 1897 - 1904
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis Xia ZhangRuiling FengJing He Brief Report Open access 07 October 2021 Pages: 1905 - 1914
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Anca D. AskanaseEnxu ZhaoRichard A. Furie Correction Open access 30 August 2021 Pages: 1915 - 1915
Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study Yiyi WangLi DingWei Li Correction Open access 02 September 2021 Pages: 1917 - 1918
Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis Tanjila KhanRicardo J. JoséMaria Mouyis Correction Open access 27 September 2021 Pages: 1919 - 1919
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data Markus RehbergClemens Giegerichthe MOBILITY, MONARCH, TARGET, and ASCERTAIN investigators Correction Open access 29 October 2021 Pages: 1921 - 1922
